Liao G - Search Results

1

New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies.

Li S, Fan J, Peng C, Chang Y, Guo L, Hou J, Huang M, Wu B, Zheng J, Lin L, Xiao G, Chen W, Liao G, Guo J, Sun P. Li S, et al. Among authors: liao g. Sci Rep. 2017 Sep 14;7(1):11525. doi: 10.1038/s41598-017-10618-1. Sci Rep. 2017. PMID: 28912450 Free PMC article.

2

Design and prediction of new anticoagulants as a selective Factor IXa inhibitor via three-dimensional quantitative structure-property relationships of amidinobenzothiophene derivatives.

Gao JS, Tong XP, Chang YQ, He YX, Mei YD, Tan PH, Guo JL, Liao GC, Xiao GK, Chen WM, Zhou SF, Sun PH. Gao JS, et al. Drug Des Devel Ther. 2015 Mar 23;9:1743-59. doi: 10.2147/DDDT.S75282. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25848211 Free PMC article.

3

An Overview of HDAC Inhibitors and their Synthetic Routes.

Peng X, Liao G, Sun P, Yu Z, Chen J. Peng X, et al. Among authors: liao g. Curr Top Med Chem. 2019;19(12):1005-1040. doi: 10.2174/1568026619666190227221507. Curr Top Med Chem. 2019. PMID: 30827245 Review.

4

Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.

Zhou Z, Mandal SS, Liao G, Guo J, Guo Z. Zhou Z, et al. Among authors: liao g. Sci Rep. 2017 Sep 12;7(1):11403. doi: 10.1038/s41598-017-11500-w. Sci Rep. 2017. PMID: 28900154 Free PMC article.

5

The Development of Biologically Important Spirooxindoles as New Antimicrobial Agents.

Yang YT, Zhu JF, Liao G, Xu HJ, Yu B. Yang YT, et al. Among authors: liao g. Curr Med Chem. 2018;25(19):2233-2244. doi: 10.2174/0929867325666171129131311. Curr Med Chem. 2018. PMID: 29189121 Review.

6

The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.

Liao G, Yang D, Ma L, Li W, Hu L, Zeng L, Wu P, Duan L, Liu Z. Liao G, et al. Eur J Med Chem. 2018 Nov 5;159:1-9. doi: 10.1016/j.ejmech.2018.09.044. Epub 2018 Sep 18. Eur J Med Chem. 2018. PMID: 30253242 Review.

7

Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.

Cao H, Li L, Yang D, Zeng L, Yewei X, Yu B, Liao G, Chen J. Cao H, et al. Among authors: liao g. Eur J Med Chem. 2019 Oct 1;179:537-546. doi: 10.1016/j.ejmech.2019.06.072. Epub 2019 Jun 28. Eur J Med Chem. 2019. PMID: 31276898 Review.

8

Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy.

Fang Y, Yang C, Teng D, Su S, Luo X, Liu Z, Liao G. Fang Y, et al. Among authors: liao g. Bioorg Chem. 2021 Apr;109:104723. doi: 10.1016/j.bioorg.2021.104723. Epub 2021 Feb 10. Bioorg Chem. 2021. PMID: 33618250

9

Discovery of natural product-like spirooxindole derivatives as highly potent and selective LSD1/KDM1A inhibitors for AML treatment.

Yang C, Fang Y, Luo X, Teng D, Liu Z, Zhou Y, Liao G. Yang C, et al. Among authors: liao g. Bioorg Chem. 2022 Mar;120:105596. doi: 10.1016/j.bioorg.2022.105596. Epub 2022 Jan 6. Bioorg Chem. 2022. PMID: 35051709

10

Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.

Fang Y, Liao G, Yu B. Fang Y, et al. Among authors: liao g. Curr Top Med Chem. 2019;19(11):889-891. doi: 10.2174/156802661911190725094910. Curr Top Med Chem. 2019. PMID: 31389779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,037 results

Search Page

Filters